ArticleCannabis and cannabinoid research2021
Origin of Δ
Article in Cannabis and cannabinoid research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 22 citations in OpenAlex.
- Poorly labeled CBD and related cannabinoid oils marketed in Europe: a hidden risk for consumers? Insights from a long-term study.Analytical and bioanalytical chemistry · 2026Article
- Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations.Molecules (Basel, Switzerland) · 2025Article
- A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol.Analytical and bioanalytical chemistry · 2024Article
- Stable Isotope Ratio Analysis for Authentication of Natural Antioxidant Cannabidiol (CBD) fromAntioxidants (Basel, Switzerland) · 2023Article
- Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).Scientific reports · 2023Article
- Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.Journal of food and drug analysis · 2023Article
- Characterizing the degradation of cannabidiol in an e-liquid formulation.Scientific reports · 2022Article
- Selective Preparation and High Dynamic-Range Analysis of Cannabinoids in "CBD Oil" and OtherJournal of natural products · 2022Article
- Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone.Clinical, cosmetic and investigational dermatology · 2022Article
- Cannabidiol-Loaded Mixed Polymeric Micelles of Chitosan/Poly(Vinyl Alcohol) and Poly(Methyl Methacrylate) for Trans-Corneal Delivery.Pharmaceutics · 2021Article
- Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells.Molecules (Basel, Switzerland) · 2021Article
- Towards Better Delivery of Cannabidiol (CBD).Pharmaceuticals (Basel, Switzerland) · 2020Review
- Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market - response to the European Industrial Hemp Association.F1000Research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.